Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achie...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2009-09-01
|
| Col·lecció: | PLoS Pathogens |
| Accés en línia: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1000594&type=printable |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
